Since 2006 HRI has tracked a slow but steady expansion of services through its biennial Global State of Harm Reduction report. 2016 is the first year where no new countries have initiated NSPs. In some countries NSP and OST site provision has fallen since 2014.
Services to reduce drug-related harms are failing to keep up with growing need, despite pledges to combat AIDS among people who inject drugs
The drive to scale-up needle and syringe programmes and opioid substitution therapy for people who inject drugs has stalled, according to a new report released today by Harm Reduction International (HRI).
Despite a UN pledge to end AIDS by 2030, no new countries have established needle and syringe programmes (NSP) since 2014. Out of 158 countries where injecting drug use is reported, 68 still do not provide NSP, while opioid substitution therapy (OST) has been initiated in just three new countries (Monaco, Senegal and Kenya), bringing the total to 80.
Report author Katie Stone said: “The 2011 UN target to halve HIV among people who inject drugs by 2015 was missed by 80%. Now people who inject drugs are being ever further left behind. In addition, emerging trends such as rising rates of amphetamine injection and overdose death are likely to see the challenges intensify. Without increased political and financial leadership we will not end AIDS or meet other global goals relating to people who use drugs.”